Left Atrial Appendage (LAA) Occluders
This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.
Videos | Left Atrial Appendage (LAA) Occluders | November 14, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital...
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.
Feature | Left Atrial Appendage (LAA) Occluders | September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to...
News | Left Atrial Appendage (LAA) Occluders | April 25, 2017
April 25, 2017 — AtriCure Inc. announced it has sold more than 100,000 AtriClip Left Atrial Appendage Exclusion System...
The AtriCure Atriclip surgical LAA occlusion device. It loops over the LAA on the outside of the heart and clips it off from the rest of the heart to prevent the formation of clots.
Feature | Left Atrial Appendage (LAA) Occluders | March 29, 2017
March 29, 2017 — For patients with atrial fibrillation (AFib), closing the area of the heart known as the left atrial...
Technology | Left Atrial Appendage (LAA) Occluders | March 22, 2017
March 22, 2017 — Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption...
Dr. Dee Dee Wang with part of Henry Ford Hospital's collection of 3-D printed hearts used for education and to preplan structural heart procedures.
Feature | Medical 3-D Printing | March 03, 2017
March 3, 2017 — A Henry Ford Hospital study found a 100 percent success rate in left atrial appendage (LAA) occlusion...
News | Left Atrial Appendage (LAA) Occluders | January 06, 2017
January 6, 2017 — SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial...
Feature | Left Atrial Appendage (LAA) Occluders | November 07, 2016
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high...
News | Atrial Fibrillation | October 25, 2016
October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE ...
News | Left Atrial Appendage (LAA) Occluders | October 20, 2016
October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of...
News | Left Atrial Appendage (LAA) Occluders | October 13, 2016
October 13, 2016 — SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical...
The CardioKinetix Parachute device implant shown deployed in the left ventricle of a heart failure patient. The device helps remodel the ventricle to improve the heart's ability to pump blood more efficiently.
Feature | Heart Failure | September 29, 2016 | Abha Mishra
New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the...
News | Left Atrial Appendage (LAA) Occluders | September 02, 2016
September 2, 2016 — St. Jude Medical Inc. announced the start of the St. Jude Medical Amplatzer Amulet IDE trial of the...
The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves.
Feature | August 05, 2016 | Dave Fornell
August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology (...
An illustration of a Watchman transcatheter LAA occluder being implanted.
Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell
Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...
